米カリフォルニア州レイクフォレスト & 東京–(BUSINESS WIRE)–（ビジネスワイヤ）– 眼内レンズおよび付属挿入システムの開発・製造・販売を手掛けるリーディングカンパニーであるスター・サージカル（NASDAQ: STAA）は本日、日本で5カ所の施設を持つ眼科治療グループの先進会眼科と戦略的提携契約を結んだと発表しました。他の戦略的提携契約と同様に、本契約には当社の眼内コラマーレンズ（ICL）のボリュームコミットメント、ICL術者の研修と認定、患者啓蒙ツール、共同マーケティングが含ま…
Author: Business Wire
STAAR Surgical Announces Strategic Cooperation Agreement with Senshinkai Eye Institute, A Leading Eye Care Chain in Japan
LAKE FOREST, Calif. & TOKYO–(BUSINESS WIRE)–STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of implantable lenses and companion delivery systems for the eye, today announced that it entered a strategic cooperatio…
Global Ophthalmology Therapeutics Market 2020-2024 | Evolving Opportunities with AbbVie Inc. and Aerie Pharmaceuticals Inc. | Technavio
LONDON–(BUSINESS WIRE)– #Biotechnology–The ophthalmology therapeutics market is poised to grow by USD 10.42 billion during 2020-2024, progressing at a CAGR of almost 6%.
STAAR Surgical Announces the EVO Implantable Lens US Clinical Trial is Underway with 1st Patient Implanted at Price Vision Group in Indianapolis on January 30th
LAKE FOREST, Calif. & INDIANAPOLIS–(BUSINESS WIRE)–STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of implantable lenses and companion delivery systems for the eye, today announced the first patient was implanted…
PRISM Vision Group Announces Affiliation with The Retina Care Center
UNION, N.J.–(BUSINESS WIRE)–PRISM Vision Group™ announces its affiliation with The Retina Care Center.
Global Pipeline Review for Optic Neuritis – H2 2019 – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Optic Neuritis – Pipeline Review, H2 2019” drug pipelines has been added to ResearchAndMarkets.com’s offering. This report provides comprehensive information on the therapeutics under development for Optic Neuritis (Ophtha…
Acucela Meets with NASA and TRISH for Phase 1 Update for SS-OCT Project
SEATTLE–(BUSINESS WIRE)–Acucela Inc. (“Acucela”), a clinical-stage ophthalmology company and wholly-owned subsidiary of Kubota Pharmaceutical Holdings Co., Ltd. (Tokyo 4596), announced today that the company was invited to meet with NASA and the Tran…
Aerie Pharmaceuticals Announces Appointment of Michelle Senchyna, Ph.D., as Vice President, Clinical Development and Medical Affairs
DURHAM, N.C.–(BUSINESS WIRE)–Aerie Pharmaceuticals, Inc. (NASDAQ:AERI), an ophthalmic pharmaceutical company focused on the discovery, development and commercialization of first-in-class therapies for the treatment of patients with open-angle glaucom…
Amir Shojaei, PharmD, PhD, to Join iVeena Board of Directors
SALT LAKE CITY–(BUSINESS WIRE)–iVeena Delivery Systems, Inc. (iVeena), a clinical stage biopharmaceutical company with developmental products in cornea and cataract, announces the appointment of Dr. Amir Shojaei to the iVeena Board of Directors. Dr. …
Zenni Sets Its Sights on Super Bowl Advertising
NOVATO, Calif.–(BUSINESS WIRE)– #eyewear–Zenni to Premiere First National Super Sunday Commercial featuring San Francisco 49ers All-Pro Tight End George Kittle.
EyeTech™ Launches EyeOn™, the Ultra-Compact Eye-Tracking Tablet Platform, Powered by Health AI, with FPGA for an Enhanced, Personalized User Experience
MESA, Ariz.–(BUSINESS WIRE)– #AAC–EyeOn is an all-in-one, ultra-slim eye gaze tablet that enables paralyzed individuals to control the device hands-free using only eye movements.
Midwest Vision Partners Announces Partnership with Specialty Eye Institute
CHICAGO & JACKSON, Mich.–(BUSINESS WIRE)–Midwest Vision Partners (“MVP”) is pleased to announce its partnership with Specialty Eye Institute (“SEI”). This represents MVP’s fourth partnership and bolsters its presence in both Michigan and Ohio. MVP is…
The Global Ophthalmic Device Market is Projected to Reach More Than US$ 67 Billion by the End of 2026 – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Ophthalmic Devices Market Global Forecast by Application, Products, Regions, Companies” report has been added to ResearchAndMarkets.com’s offering. The Global Ophthalmic Device Market is projected to reach more than US$ 67…
KLAS 2019 Report Names Modernizing Medicine’s EMA a Top-Rated Ophthalmology EMR System for Overall Customer Experience
BOCA RATON, Fla.–(BUSINESS WIRE)–KLAS 2019 Report Names Modernizing Medicine’s EMA a Top-Rated Ophthalmology EMR System for Overall Customer Experience
SmartHealth PayCard Offers Healthcare Providers and Millions of Americans Transformative Financial Solutions for Medical Expenses
DALLAS–(BUSINESS WIRE)–SmartHealth PayCard launches the first and only credit card restricted to healthcare, offering patients and providers innovative financial solutions.
Aldeyra Therapeutics Appoints Dr. Paul Karpecki to Anterior Segment Scientific Advisory Board
LEXINGTON, Mass.–(BUSINESS WIRE)–Aldeyra Therapeutics Appoints Dr. Paul Karpecki to Anterior Segment Scientific Advisory Board
Bruker Announces Date and Time of Fourth Quarter 2019 Earnings Release and Webcast
BILLERICA, Mass.–(BUSINESS WIRE)–Bruker Corporation: Date and Time of Fourth Quarter 2019 Earnings Release and Webcast
Americans Want More from Eye Care But Fear Costs, Finds New Study
BALTIMORE, Md.–(BUSINESS WIRE)– #eye–Versant Health releases the 2020 Vision Wellness Study, finding that cost concerns could be keeping Americans from visiting their eye doctors.
Horizon Therapeutics plc Announces Changes in Research and Development Organization
DUBLIN–(BUSINESS WIRE)–Horizon Therapeutics plc (Nasdaq: HZNP) today announced changes to its research and development organization structure. Effective immediately, Elizabeth H.Z. Thompson, Ph.D., group vice president, clinical development and exter…
Le programme clinique d’Ipsen pour le palovarotène dans la fibrodysplasie ossifiante progressive atteint le critère de futilité lors de l’analyse intérimaire prévue au protocole
PARIS–(BUSINESS WIRE)–Regulatory News: Ipsen (Euronext : IPN ; ADR : IPSEY) a annoncé aujourd’hui sa décision de suspendre l’administration du traitement aux patients recrutés dans l’étude globale de phase III (PVO-1A-301) destinée à évaluer l’effica…